Auteurs
Analysis
USA
Racine
Analysis
USA
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)

Index « Auteurs » - entrée « Yoshikuni Mizuno »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yoshikino Mizuno < Yoshikuni Mizuno < Yoshio Momose  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000150 (2014) Robert A. Hauser [États-Unis] ; Mark Forrest Gordon [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Paolo Barone [Italie] ; Anthony H. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Catherine Debieuvre [France] ; Mandy Fr Dorf [Allemagne]Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
000211 (2013) Anthony Hv Schapira [Royaume-Uni] ; Michael P. Mcdermott [États-Unis] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Stefan Albrecht [Allemagne] ; Helen H. Hsu [États-Unis] ; Daniel H. Massey [Royaume-Uni] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
000452 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000453 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000466 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000606 (2007) Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Parkinson's disease
3Nervous system diseases
3Parkinson disease
3Pramipexole
2Dopamine agonist
2Humans
2Release
2dopamine agonist
1Activities of Daily Living
1Aged
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Benzothiazoles (administration & dosage)
1Benzothiazoles (adverse effects)
1Cognition Disorders (etiology)
1Cognition Disorders (psychology)
1Confidence Intervals
1Delayed-Action Preparations (therapeutic use)
1Dementia (diagnosis)
1Dementia (etiology)
1Dementia (psychology)
1Dose-Response Relationship, Drug
1Double-Blind Method
1Drug Administration Schedule
1Evaluation
1Female
1Male
1Memory Disorders (etiology)
1Memory Disorders (psychology)
1Middle Aged
1PD dementia
1Parkinson Disease (complications)
1Parkinson Disease (drug therapy)
1Parkinson Disease (psychology)
1Psychomotor Performance (physiology)
1Safety
1Severity of Illness Index
1Time Factors
1Treatment
1clinical trial
1delayed‐start
1diagnostic criteria
1executive functions
1neuroprotection
1pramipexole
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1task force
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/USA/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Yoshikuni Mizuno" 

HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Yoshikuni Mizuno" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshikuni Mizuno
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024